These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15603893)

  • 21. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of universal influenza vaccination of children in pediatric practices.
    Yoo BK; Szilagyi PG; Schaffer SJ; Humiston SG; Rand CM; Albertin CS; Vincelli P; Blumkin AK; Shone LP; Coleman MS
    Pediatrics; 2009 Dec; 124 Suppl 5(Suppl 5):S499-506. PubMed ID: 19948581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of vaccination clinics; user fees for investigational new drug (IND) influenza vaccine services and vaccines. Interim final rule and request for comments.
    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
    Fed Regist; 2005 Jan; 70(15):3490-3. PubMed ID: 15669145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
    Hibbert CL; Piedra PA; McLaurin KK; Vesikari T; Mauskopf J; Mahadevia PJ
    Vaccine; 2007 Nov; 25(47):8010-20. PubMed ID: 17936446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons.
    Nichol KL; Nordin J; Mullooly J
    Vaccine; 2006 Mar; 24(10):1562-8. PubMed ID: 16300868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.
    Aballéa S; De Juanes JR; Barbieri M; Martin M; Chancellor J; Oyagüez I; Verwee B; Largeron N
    Vaccine; 2007 Sep; 25(39-40):6900-10. PubMed ID: 17764790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of influenza vaccination timing.
    Yoo BK; Frick K
    Health Econ; 2005 Aug; 14(8):777-91. PubMed ID: 15700301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An economic analysis of annual influenza vaccination of children.
    Meltzer MI; Neuzil KM; Griffin MR; Fukuda K
    Vaccine; 2005 Jan; 23(8):1004-14. PubMed ID: 15620473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Vote and Vax program: public health at polling places.
    Shenson D; Adams M
    J Public Health Manag Pract; 2008; 14(5):476-80. PubMed ID: 18708892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3-14 years during the annual health examination in private paediatric offices.
    Salleras L; Navas E; Domínguez A; Ibáñez D; Prat A; Garrido P; Asenjo MA; Torner N
    Vaccine; 2009 May; 27(25-26):3454-8. PubMed ID: 19200830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in the costs of delivering routine immunization services in Peru.
    Walker D; Mosqueira NR; Penny ME; Lanata CF; Clark AD; Sanderson CF; Fox-Rushby JA
    Bull World Health Organ; 2004 Sep; 82(9):676-82. PubMed ID: 15628205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community.
    Praditsuwan R; Assantachai P; Wasi C; Puthavatana P; Kositanont U
    J Med Assoc Thai; 2005 Feb; 88(2):256-64. PubMed ID: 15962680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccination cost effective in U.S. adults.
    Geriatrics; 2006 Feb; 61(2):14. PubMed ID: 16502520
    [No Abstract]   [Full Text] [Related]  

  • 35. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain.
    López-de-Andrés A; Carrasco-Garrido P; Hernández-Barrera V; de Miguel AG; Jiménez-García R
    Eur J Public Health; 2008 Apr; 18(2):173-7. PubMed ID: 17875577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.
    Cai L; Uchiyama H; Yanagisawa S; Kamae I
    Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New accounting system helps control costs.
    Wymelenberg S
    Hospitals; 1979 Jul; 53(13):68-70. PubMed ID: 437733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health economic research on vaccinations and immunisation practices--an introductory primer.
    Szucs TD
    Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.